PSNC seeks new CEO following Simon Dukes’s resignation from the role

PSNC has already started the recruitment process to appoint a new CEO, following Simon Dukes’s resignation from the role, it has announced.

Simon%20Duke2_0%20%281%29_0_0_0_0.jpg
Simon Dukes will remain in post until the end of September, according to PSNC

Mr Dukes – who has served as the Pharmaceutical Services Negotiating Committee (PSNC) CEO for the past three years – will remain in post until the end of September, PSNC said in a statement this afternoon (July 20).

He will continue to lead on the work to agree on the arrangements on the 2021/22 pharmacy funding contract in England alongside the NHS and the government, PSNC said.

A PSNC spokesperson told C+D today that Mr Dukes will leave the top job at the English negotiating body to chair Fair for You, a not-for-profit online lending company.

PSNC has already started the recruitment process to hire Mr Dukes’s replacement and further information on this is expected “in due course”.

Stepping down now is “opportune”

Commenting on his resignation, Mr Dukes said that “deciding to step down was never going to be easy, but I do believe now is opportune”.

“It has been an honour to serve as chief executive of PSNC for the last three years, and a genuine privilege to work with such a dedicated, knowledgeable, and unbelievably hard-working senior team and committee,” he added.

Mr Dukes joined PSNC in 2018 from counter-fraud organisation CIFAS. During his tenure, he was responsible for leading the organisation on agreeing on a five-year funding settlement and helped support contractors during the pandemic.

Mr Dukes pointed to several highlights of his time as PSNC CEO, including improved relationships between the negotiator and NHS England & NHS Improvement and the Department of Health and Social Care; the settlement of COVID-19 costs for contractors; and the initiation of the independent review of both PSNC and local pharmaceutical committees.

“Demanding but rewarding role

Mr Dukes said his successor will be able to “engage fully with the changes that will emerge from the independent review”.

PSNC chair Sue Killen thanked Mr Dukes for “all that he has done, and is continuing to do, for community pharmacy”.

Being the PSNC CEO “is a demanding but hugely rewarding role, balancing the extensive stakeholder engagement work needed to support the sector, with the tactical side of the negotiations, and of course, leading a small and incredibly busy team doing complex but vital work”, Ms Killen added.

Sign in or register for free

Latest from News

‘Very desperate’: Boom in pay-for-DPP services as GP surgery ‘doors close’

 
• By 
 • comment0

A snowballing number of pharmacists who “feel like they're missing out” are willing to fork out thousands for a Designated Prescribing Practitioner (DPP) to complete their independent prescribing (IP) qualification, C+D has learned.

Patient secures ‘urgent’ leukaemia treatment after Pharmacy First consultation

 
• By 
 • comment0

A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.

PDA releases ‘six-step test’ for the next funding contract

 
• By 
 • comment2

It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.

More from Funding

exclusive

Nick Kaye: ‘The NPA isn’t in any mood to back down’

 
• By 
 • comment

Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.

DH to place ‘explicit restrictions’ on funded blood pressure checks

  • comment

The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.